LSC Webinars

1. Building a Global Manufacturing Network: "Dual-Sourcing" Commercial Strategies 10/19/2026

   EU entry after FDA approval puts launch timing and supply continuity at risk. QP release, importation pathways, and distributed manufacturing networks all shape whether a biologic reaches the market predictably.

2. Precision At Scale: Optimizing Cell-Free DNA Manufacturing For mRNA Vaccines 10/16/2026

   Backbone-free enzymatic DNA templates can improve polyA integrity, long-transcript quality, and RNA yield, with implications for IVT timelines and regulation.

3. Developing Custom GMP Lipids: A Patient-Driven Partnership 10/8/2026

   Custom lipid programs depend on how process development and manufacturing teams collaborate, from first design through scale-up to GMP production for LNP-based therapies.

4. Smarter Lead Selection And Faster Representative Material 10/6/2026

   Accelerate biologics development with earlier high-titer material, reduced CMC risk, and faster lead selection using transposase-based vectors and stable bulk pools.

5. APAC Scaling AAV manufacturing to 1000 L: strategies for robust and reproducible production 9/30/2026
6. Scaling AAV Manufacturing To 1000 L: Strategies For Robust And Reproducible Production 9/30/2026
7. Design Verification Done Right: Smarter Strategies For Prefillable Syringes 9/29/2026

   A practical framework for planning and justifying design verification programs for prefillable syringes, covering test selection, acceptance criteria, and sample-size rationale within a risk-based approach.

8. IND In As Little As 6 Months: Now Beyond mAbs - Accelerating Bispecifics, Fc-Fusions And High-Concentration Biologics To The Clinic 9/25/2026

   Listen as our experts outline expanded accelerated DNA-to-IND pathways for a broader range of biologic modalities, examining how expression technologies and integrated CMC strategies can shorten development timelines.

9. Scaling Cell And Gene Therapy Manufacturing 9/25/2026

   Artificial intelligence is reshaping healthcare. Discover proven strategies for secure, compliant AI adoption, strong data governance, and seamless integration to improve patient outcomes.

10. De-Risking The Path To GMP Manufacturing At Another Organization 9/23/2026

    Successful tech transfer depends on more than moving a process. Early alignment across process readiness, analytical strategy, governance, and decision-making helps reduce execution risk.